Advanced Proteome Therapeutics Corporation
APCH.V
TSX
| 04/30/2023 | 01/31/2023 | 10/31/2022 | 07/31/2022 | 04/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 38.70K | 292.50K | 312.20K | 544.40K | 761.60K |
| Total Receivables | 22.90K | -- | 47.90K | 49.80K | 49.30K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 14.80K | 19.60K | 21.70K | 27.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 5.00K | 5.00K | 5.00K | -- |
| Total Current Assets | 61.60K | 312.30K | 384.70K | 620.90K | 838.40K |
|
|
|||||
| Total Current Assets | 61.60K | 312.30K | 384.70K | 620.90K | 838.40K |
| Net Property, Plant & Equipment | 1.10K | 13.80K | 14.40K | 15.50K | 16.70K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 62.80K | 326.10K | 399.00K | 636.40K | 855.10K |
|
|
|||||
| Total Accounts Payable | 45.30K | 309.00K | 229.10K | 251.50K | 263.40K |
| Total Accrued Expenses | 8.40K | 402.80K | 406.90K | 413.80K | 420.20K |
| Short-term Debt | 30.80K | 152.00K | 99.80K | 285.40K | 614.30K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 355.00K | 295.00K | 294.00K | 234.00K |
| Total Other Current Liabilities | -- | 355.00K | 295.00K | 294.00K | 234.00K |
| Total Current Liabilities | 84.50K | 1.22M | 1.03M | 1.24M | 1.53M |
|
|
|||||
| Total Current Liabilities | 84.50K | 1.22M | 1.03M | 1.24M | 1.53M |
| Long-Term Debt | -- | 236.60K | 220.50K | 227.40K | 177.90K |
| Short-term Debt | 30.80K | 152.00K | 99.80K | 285.40K | 614.30K |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00 | -- | -- | 15.10K | 303.80K |
| Total Liabilities | 84.50K | 1.46M | 1.25M | 1.49M | 2.01M |
|
|
|||||
| Common Stock & APIC | 20.26M | 20.26M | 20.20M | 20.20M | 20.06M |
| Retained Earnings | -20.28M | -22.79M | -22.52M | -22.31M | -22.23M |
| Treasury Stock & Other | -- | 2.90M | 2.90M | 3.17M | 2.88M |
| Total Common Equity | -21.70K | 357.60K | 579.80K | 1.07M | 719.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.70K | 357.60K | 579.80K | 1.07M | 719.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -1.49M | -1.43M | -1.92M | -1.88M |
| Total Equity | -21.70K | -1.13M | -852.30K | -850.90K | -1.16M |
|
|
|||||